Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bronchial Asthma as a Cardiovascular Risk Factor: A Prospective Observational Study.
Biomedicines. 2022 Oct 18;10(10):2614. doi: 10.3390/biomedicines10102614.
Biomedicines. 2022.
PMID: 36289876
Free PMC article.
Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry.
Vaník P, Novosad J, Kirchnerová O, Krčmová I, Teřl M; Czech Anti-IgE Registry collaborators.
Vaník P, et al. Among authors: kirchnerova o.
Allergy Asthma Clin Immunol. 2020 Sep 15;16:81. doi: 10.1186/s13223-020-00479-1. eCollection 2020.
Allergy Asthma Clin Immunol. 2020.
PMID: 32944035
Free PMC article.
Item in Clipboard
Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic.
Kirchnerová OR, Valena T, Novosad J, Teřl M; Czech eXpeRience Study Group.
Kirchnerová OR, et al.
Postepy Dermatol Alergol. 2019 Feb;36(1):34-43. doi: 10.5114/ada.2018.76606. Epub 2018 Jun 20.
Postepy Dermatol Alergol. 2019.
PMID: 30858777
Free PMC article.
Item in Clipboard
Cite
Cite